Oxibendazole inhibits prostate cancer cell growth

Prostate cancer (PCa) is one of the most common malignancies among men and is the second leading cause of cancer-associated mortality in the developed world. Androgen deprivation therapy (ADT) is the most common treatment for PCa. However, the majority of androgen-sensitive PCa patients will eventua...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiaoli, Li, Yuhua, Zhou, Xiaoyu, Li, Runsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776919/
https://www.ncbi.nlm.nih.gov/pubmed/29434928
http://dx.doi.org/10.3892/ol.2017.7579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776919/
https://www.ncbi.nlm.nih.gov/pubmed/29434928
http://dx.doi.org/10.3892/ol.2017.7579

Ejemplares similares